The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.
The global Rifaximin market was valued at US$ 71 million in 2023 and is anticipated to reach US$ 94 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
Rifaximin is an antibiotic used for the treatment of various conditions such as traveler's diarrhea and hepatic encephalopathy. The global market for rifaximin is being driven by several factors. Here are some key drivers of the rifaximin market：Increased prevalence of infectious diseases: The global prevalence of infectious diseases is on the rise, due to factors such as globalization, increased travel, and climate change. This has led to a higher demand for effective antibiotics like rifaximin. Growing awareness of antibiotic resistance: Antibiotic resistance is a growing concern worldwide, leading to an increased focus on developing and using antibiotics judiciously. Rifaximin is a non-systemic antibiotic, which means it has a lower risk of contributing to antibiotic resistance. This makes it a preferred choice for some indications. Expanding indications: Rifaximin has received regulatory approvals for the treatment of various conditions, including traveler's diarrhea, hepatic encephalopathy, and irritable bowel syndrome. The expanding list of approved indications is contributing to the market growth. Advances in healthcare infrastructure: Improvements in healthcare infrastructure, particularly in emerging markets, have increased access to advanced antibiotics like rifaximin. This has led to a wider patient pool and increased market demand. Rising healthcare expenditure: Governments and private entities are investing heavily in healthcare, including the development and distribution of antibiotics. This increased healthcare spending is supporting the availability and affordability of rifaximin, driving market growth.
This report aims to provide a comprehensive presentation of the global market for Rifaximin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifaximin.
Report Scope
The Rifaximin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rifaximin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rifaximin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Salix Pharmaceuticals
Soigner Pharma
STERIS PHARMA
Texas Pharmaceuticals
Cassopeia Pharmaceuticals
Segment by Type
200 mg Tablets
550 mg Tablets
Segment by Application
Hospital
Drug store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rifaximin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rifaximin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.
The global Rifaximin market was valued at US$ 71 million in 2023 and is anticipated to reach US$ 94 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
Rifaximin is an antibiotic used for the treatment of various conditions such as traveler's diarrhea and hepatic encephalopathy. The global market for rifaximin is being driven by several factors. Here are some key drivers of the rifaximin market：Increased prevalence of infectious diseases: The global prevalence of infectious diseases is on the rise, due to factors such as globalization, increased travel, and climate change. This has led to a higher demand for effective antibiotics like rifaximin. Growing awareness of antibiotic resistance: Antibiotic resistance is a growing concern worldwide, leading to an increased focus on developing and using antibiotics judiciously. Rifaximin is a non-systemic antibiotic, which means it has a lower risk of contributing to antibiotic resistance. This makes it a preferred choice for some indications. Expanding indications: Rifaximin has received regulatory approvals for the treatment of various conditions, including traveler's diarrhea, hepatic encephalopathy, and irritable bowel syndrome. The expanding list of approved indications is contributing to the market growth. Advances in healthcare infrastructure: Improvements in healthcare infrastructure, particularly in emerging markets, have increased access to advanced antibiotics like rifaximin. This has led to a wider patient pool and increased market demand. Rising healthcare expenditure: Governments and private entities are investing heavily in healthcare, including the development and distribution of antibiotics. This increased healthcare spending is supporting the availability and affordability of rifaximin, driving market growth.
This report aims to provide a comprehensive presentation of the global market for Rifaximin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifaximin.
Report Scope
The Rifaximin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rifaximin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rifaximin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Salix Pharmaceuticals
Soigner Pharma
STERIS PHARMA
Texas Pharmaceuticals
Cassopeia Pharmaceuticals
Segment by Type
200 mg Tablets
550 mg Tablets
Segment by Application
Hospital
Drug store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rifaximin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rifaximin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rifaximin Market Overview
1.1 Product Overview and Scope of Rifaximin
1.2 Rifaximin Segment by Type
1.2.1 Global Rifaximin Market Value Comparison by Type (2024-2030)
1.2.2 200 mg Tablets
1.2.3 550 mg Tablets
1.3 Rifaximin Segment by Application
1.3.1 Global Rifaximin Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Rifaximin Market Size Estimates and Forecasts
1.4.1 Global Rifaximin Revenue 2019-2030
1.4.2 Global Rifaximin Sales 2019-2030
1.4.3 Global Rifaximin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rifaximin Market Competition by Manufacturers
2.1 Global Rifaximin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rifaximin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rifaximin Average Price by Manufacturers (2019-2024)
2.4 Global Rifaximin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rifaximin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rifaximin, Product Type & Application
2.7 Rifaximin Market Competitive Situation and Trends
2.7.1 Rifaximin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rifaximin Players Market Share by Revenue
2.7.3 Global Rifaximin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rifaximin Retrospective Market Scenario by Region
3.1 Global Rifaximin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rifaximin Global Rifaximin Sales by Region: 2019-2030
3.2.1 Global Rifaximin Sales by Region: 2019-2024
3.2.2 Global Rifaximin Sales by Region: 2025-2030
3.3 Global Rifaximin Global Rifaximin Revenue by Region: 2019-2030
3.3.1 Global Rifaximin Revenue by Region: 2019-2024
3.3.2 Global Rifaximin Revenue by Region: 2025-2030
3.4 North America Rifaximin Market Facts & Figures by Country
3.4.1 North America Rifaximin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rifaximin Sales by Country (2019-2030)
3.4.3 North America Rifaximin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rifaximin Market Facts & Figures by Country
3.5.1 Europe Rifaximin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rifaximin Sales by Country (2019-2030)
3.5.3 Europe Rifaximin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rifaximin Market Facts & Figures by Country
3.6.1 Asia Pacific Rifaximin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rifaximin Sales by Country (2019-2030)
3.6.3 Asia Pacific Rifaximin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rifaximin Market Facts & Figures by Country
3.7.1 Latin America Rifaximin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rifaximin Sales by Country (2019-2030)
3.7.3 Latin America Rifaximin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rifaximin Market Facts & Figures by Country
3.8.1 Middle East and Africa Rifaximin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rifaximin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rifaximin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Rifaximin Sales by Type (2019-2030)
4.1.1 Global Rifaximin Sales by Type (2019-2024)
4.1.2 Global Rifaximin Sales by Type (2025-2030)
4.1.3 Global Rifaximin Sales Market Share by Type (2019-2030)
4.2 Global Rifaximin Revenue by Type (2019-2030)
4.2.1 Global Rifaximin Revenue by Type (2019-2024)
4.2.2 Global Rifaximin Revenue by Type (2025-2030)
4.2.3 Global Rifaximin Revenue Market Share by Type (2019-2030)
4.3 Global Rifaximin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rifaximin Sales by Application (2019-2030)
5.1.1 Global Rifaximin Sales by Application (2019-2024)
5.1.2 Global Rifaximin Sales by Application (2025-2030)
5.1.3 Global Rifaximin Sales Market Share by Application (2019-2030)
5.2 Global Rifaximin Revenue by Application (2019-2030)
5.2.1 Global Rifaximin Revenue by Application (2019-2024)
5.2.2 Global Rifaximin Revenue by Application (2025-2030)
5.2.3 Global Rifaximin Revenue Market Share by Application (2019-2030)
5.3 Global Rifaximin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Salix Pharmaceuticals
6.1.1 Salix Pharmaceuticals Corporation Information
6.1.2 Salix Pharmaceuticals Description and Business Overview
6.1.3 Salix Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Salix Pharmaceuticals Rifaximin Product Portfolio
6.1.5 Salix Pharmaceuticals Recent Developments/Updates
6.2 Soigner Pharma
6.2.1 Soigner Pharma Corporation Information
6.2.2 Soigner Pharma Description and Business Overview
6.2.3 Soigner Pharma Rifaximin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Soigner Pharma Rifaximin Product Portfolio
6.2.5 Soigner Pharma Recent Developments/Updates
6.3 STERIS PHARMA
6.3.1 STERIS PHARMA Corporation Information
6.3.2 STERIS PHARMA Description and Business Overview
6.3.3 STERIS PHARMA Rifaximin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 STERIS PHARMA Rifaximin Product Portfolio
6.3.5 STERIS PHARMA Recent Developments/Updates
6.4 Texas Pharmaceuticals
6.4.1 Texas Pharmaceuticals Corporation Information
6.4.2 Texas Pharmaceuticals Description and Business Overview
6.4.3 Texas Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Texas Pharmaceuticals Rifaximin Product Portfolio
6.4.5 Texas Pharmaceuticals Recent Developments/Updates
6.5 Cassopeia Pharmaceuticals
6.5.1 Cassopeia Pharmaceuticals Corporation Information
6.5.2 Cassopeia Pharmaceuticals Description and Business Overview
6.5.3 Cassopeia Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cassopeia Pharmaceuticals Rifaximin Product Portfolio
6.5.5 Cassopeia Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rifaximin Industry Chain Analysis
7.2 Rifaximin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rifaximin Production Mode & Process
7.4 Rifaximin Sales and Marketing
7.4.1 Rifaximin Sales Channels
7.4.2 Rifaximin Distributors
7.5 Rifaximin Customers
8 Rifaximin Market Dynamics
8.1 Rifaximin Industry Trends
8.2 Rifaximin Market Drivers
8.3 Rifaximin Market Challenges
8.4 Rifaximin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rifaximin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rifaximin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Rifaximin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rifaximin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rifaximin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rifaximin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rifaximin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rifaximin Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rifaximin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rifaximin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rifaximin, Product Type & Application
Table 12. Global Key Manufacturers of Rifaximin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rifaximin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifaximin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rifaximin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rifaximin Sales by Region (2019-2024) & (K Units)
Table 18. Global Rifaximin Sales Market Share by Region (2019-2024)
Table 19. Global Rifaximin Sales by Region (2025-2030) & (K Units)
Table 20. Global Rifaximin Sales Market Share by Region (2025-2030)
Table 21. Global Rifaximin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rifaximin Revenue Market Share by Region (2019-2024)
Table 23. Global Rifaximin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rifaximin Revenue Market Share by Region (2025-2030)
Table 25. North America Rifaximin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rifaximin Sales by Country (2019-2024) & (K Units)
Table 27. North America Rifaximin Sales by Country (2025-2030) & (K Units)
Table 28. North America Rifaximin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rifaximin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rifaximin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rifaximin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rifaximin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rifaximin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rifaximin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rifaximin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rifaximin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rifaximin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rifaximin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rifaximin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rifaximin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rifaximin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rifaximin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rifaximin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rifaximin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rifaximin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Rifaximin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Rifaximin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Rifaximin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rifaximin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rifaximin Sales (K Units) by Type (2019-2024)
Table 51. Global Rifaximin Sales (K Units) by Type (2025-2030)
Table 52. Global Rifaximin Sales Market Share by Type (2019-2024)
Table 53. Global Rifaximin Sales Market Share by Type (2025-2030)
Table 54. Global Rifaximin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rifaximin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rifaximin Revenue Market Share by Type (2019-2024)
Table 57. Global Rifaximin Revenue Market Share by Type (2025-2030)
Table 58. Global Rifaximin Price (USD/Unit) by Type (2019-2024)
Table 59. Global Rifaximin Price (USD/Unit) by Type (2025-2030)
Table 60. Global Rifaximin Sales (K Units) by Application (2019-2024)
Table 61. Global Rifaximin Sales (K Units) by Application (2025-2030)
Table 62. Global Rifaximin Sales Market Share by Application (2019-2024)
Table 63. Global Rifaximin Sales Market Share by Application (2025-2030)
Table 64. Global Rifaximin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rifaximin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rifaximin Revenue Market Share by Application (2019-2024)
Table 67. Global Rifaximin Revenue Market Share by Application (2025-2030)
Table 68. Global Rifaximin Price (USD/Unit) by Application (2019-2024)
Table 69. Global Rifaximin Price (USD/Unit) by Application (2025-2030)
Table 70. Salix Pharmaceuticals Corporation Information
Table 71. Salix Pharmaceuticals Description and Business Overview
Table 72. Salix Pharmaceuticals Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Salix Pharmaceuticals Rifaximin Product
Table 74. Salix Pharmaceuticals Recent Developments/Updates
Table 75. Soigner Pharma Corporation Information
Table 76. Soigner Pharma Description and Business Overview
Table 77. Soigner Pharma Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Soigner Pharma Rifaximin Product
Table 79. Soigner Pharma Recent Developments/Updates
Table 80. STERIS PHARMA Corporation Information
Table 81. STERIS PHARMA Description and Business Overview
Table 82. STERIS PHARMA Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. STERIS PHARMA Rifaximin Product
Table 84. STERIS PHARMA Recent Developments/Updates
Table 85. Texas Pharmaceuticals Corporation Information
Table 86. Texas Pharmaceuticals Description and Business Overview
Table 87. Texas Pharmaceuticals Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Texas Pharmaceuticals Rifaximin Product
Table 89. Texas Pharmaceuticals Recent Developments/Updates
Table 90. Cassopeia Pharmaceuticals Corporation Information
Table 91. Cassopeia Pharmaceuticals Description and Business Overview
Table 92. Cassopeia Pharmaceuticals Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Cassopeia Pharmaceuticals Rifaximin Product
Table 94. Cassopeia Pharmaceuticals Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Rifaximin Distributors List
Table 98. Rifaximin Customers List
Table 99. Rifaximin Market Trends
Table 100. Rifaximin Market Drivers
Table 101. Rifaximin Market Challenges
Table 102. Rifaximin Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rifaximin
Figure 2. Global Rifaximin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rifaximin Market Share by Type in 2023 & 2030
Figure 4. 200 mg Tablets Product Picture
Figure 5. 550 mg Tablets Product Picture
Figure 6. Global Rifaximin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Rifaximin Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug store
Figure 10. Global Rifaximin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Rifaximin Market Size (2019-2030) & (US$ Million)
Figure 12. Global Rifaximin Sales (2019-2030) & (K Units)
Figure 13. Global Rifaximin Average Price (USD/Unit) & (2019-2030)
Figure 14. Rifaximin Report Years Considered
Figure 15. Rifaximin Sales Share by Manufacturers in 2023
Figure 16. Global Rifaximin Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Rifaximin Players: Market Share by Revenue in 2023
Figure 18. Rifaximin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Rifaximin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Rifaximin Sales Market Share by Country (2019-2030)
Figure 21. North America Rifaximin Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Rifaximin Sales Market Share by Country (2019-2030)
Figure 25. Europe Rifaximin Revenue Market Share by Country (2019-2030)
Figure 26. Germany Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Rifaximin Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Rifaximin Revenue Market Share by Region (2019-2030)
Figure 33. China Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Rifaximin Sales Market Share by Country (2019-2030)
Figure 44. Latin America Rifaximin Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Rifaximin Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Rifaximin Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Rifaximin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Rifaximin by Type (2019-2030)
Figure 54. Global Revenue Market Share of Rifaximin by Type (2019-2030)
Figure 55. Global Rifaximin Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Rifaximin by Application (2019-2030)
Figure 57. Global Revenue Market Share of Rifaximin by Application (2019-2030)
Figure 58. Global Rifaximin Price (USD/Unit) by Application (2019-2030)
Figure 59. Rifaximin Value Chain
Figure 60. Rifaximin Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
